On October 24, 2019 DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) ("DelMar" or the "Company"), a biopharmaceutical company focused on the development of new cancer therapies, reported that Mr. Saiid Zarrabian, president and chief executive officer of DelMar, will be a featured presenter at the 5th Annual Dawson James Small Cap Growth Conference on October 29, 2019 at 4:05 PM Eastern Time (Press release, DelMar Pharmaceuticals, OCT 24, 2019, View Source [SID1234542475]). The conference is being held at the Wyndham Grand Hotel in Jupiter, Florida.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Mr. Zarrabian will provide an overview of the Company’s business model and growth strategy and will be available for one-on-one meetings. Interested investors may request a meeting time by contacting conference coordinator Karen Payne at [email protected].